Characterization of excipient enhanced growth (EEG) tobramycin dry powder aerosol formulations.

Hassan, Amr; Farkas, Dale; Longest, Worth; Hindle, Michael

Hassan, Amr; Farkas, Dale; Longest, Worth; Hindle, Michael.

Afiliación

Hassan A; Department of Pharmaceutics, Virginia Commonwealth University, Richmond, VA, USA. Electronic address: aahassan2@vcu.edu.
Farkas D; Department of Mechanical and Nuclear Engineering, Virginia Commonwealth University, Richmond, VA, USA.
Longest W; Department of Pharmaceutics, Virginia Commonwealth University, Richmond, VA, USA; Department of Mechanical and Nuclear Engineering, Virginia Commonwealth University, Richmond, VA, USA.
Hindle M; Department of Pharmaceutics, Virginia Commonwealth University, Richmond, VA, USA.

Int J Pharm ; 591: 120027, 2020 Dec 15.

Article en En | MEDLINE | ID: mdl-33130220

Asunto(s)

Excipientes; Tobramicina; Administración por Inhalación; Aerosoles; Inhaladores de Polvo Seco; Tamaño de la Partícula; Polvos

Palabras clave

Aerosol performance; Dry powder aerosol; Excipient enhanced growth; Hygroscopic formulation; L-leucine; Solid-state stability; Spray drying; Tobramycin

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tobramicina / Excipientes Idioma: En Revista: Int J Pharm Año: 2020 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google